Literature DB >> 22225920

Plasma antioxidant capacity is reduced in Asperger syndrome.

Mara Parellada1, Carmen Moreno, Karina Mac-Dowell, Juan Carlos Leza, Marisa Giraldez, Concepción Bailón, Carmen Castro, Patricia Miranda-Azpiazu, David Fraguas, Celso Arango.   

Abstract

Recent evidence suggests that children with autism have impaired detoxification capacity and may suffer from chronic oxidative stress. To our knowledge, there has been no study focusing on oxidative metabolism specifically in Asperger syndrome (a milder form of autism) or comparing this metabolism with other psychiatric disorders. In this study, total antioxidant status (TAOS), non-enzymatic (glutathione and homocysteine) and enzymatic (catalase, superoxide dismutase, and glutathione peroxidase) antioxidants, and lipid peroxidation were measured in plasma or erythrocyte lysates in a group of adolescent patients with Asperger syndrome, a group of adolescents with a first episode of psychosis, and a group of healthy controls at baseline and at 8-12 weeks. TAOS was also analyzed at 1 year. TAOS was reduced in Asperger individuals compared with healthy controls and psychosis patients, after covarying by age and antipsychotic treatment. This reduced antioxidant capacity did not depend on any of the individual antioxidant variables measured. Psychosis patients had increased homocysteine levels in plasma and decreased copper and ceruloplasmin at baseline. In conclusion, Asperger patients seem to have chronic low detoxifying capacity. No impaired detoxifying capacity was found in the first-episode psychosis group in the first year of illness.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225920     DOI: 10.1016/j.jpsychires.2011.10.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  16 in total

Review 1.  Deficits in bioenergetics and impaired immune response in granulocytes from children with autism.

Authors:  Eleonora Napoli; Sarah Wong; Irva Hertz-Picciotto; Cecilia Giulivi
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

Review 2.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

3.  Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder.

Authors:  Kunio Yui; Nasoyuki Tanuma; Hiroshi Yamada; Yohei Kawasaki
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-01       Impact factor: 4.223

4.  Biphasic regulation of lysosomal exocytosis by oxidative stress.

Authors:  Sreeram Ravi; Karina A Peña; Charleen T Chu; Kirill Kiselyov
Journal:  Cell Calcium       Date:  2016-08-29       Impact factor: 6.817

Review 5.  Impaired Redox Control in Autism Spectrum Disorders: Could It Be the X in GxE?

Authors:  Vanja Mandic-Maravic; Marija Pljesa-Ercegovac; Marija Mitkovic-Voncina; Ana Savic-Radojevic; Dusica Lecic-Tosevski; Tatjana Simic; Milica Pejovic-Milovancevic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

6.  Effects of Hyperthermia on TRPV1 and TRPV4 Channels Expression and Oxidative Markers in Mouse Brain.

Authors:  Aida Aghazadeh; Mohammad Ali Hosseinpour Feizi; Leila Mehdizadeh Fanid; Mohammad Ghanbari; Leila Roshangar
Journal:  Cell Mol Neurobiol       Date:  2020-07-13       Impact factor: 5.046

7.  Psychopathology in children and adolescents with ASD without mental retardation.

Authors:  Marta Caamaño; Leticia Boada; Jessica Merchán-Naranjo; Carmen Moreno; Cloe Llorente; Dolores Moreno; Celso Arango; Mara Parellada
Journal:  J Autism Dev Disord       Date:  2013-10

8.  A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors:  Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal:  BMC Psychiatry       Date:  2013-07-25       Impact factor: 3.630

Review 9.  Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and Cardioprotection.

Authors:  William D Hedrich; Hongbing Wang
Journal:  Pharm Res       Date:  2021-02-22       Impact factor: 4.200

10.  Ubiquinol improves symptoms in children with autism.

Authors:  Anna Gvozdjáková; Jarmila Kucharská; Daniela Ostatníková; Katarína Babinská; Dalibor Nakládal; Fred L Crane
Journal:  Oxid Med Cell Longev       Date:  2014-02-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.